Cell selectivity and interaction with model membranes of Val/Arg-rich peptides

Journal of Peptide Science

Volumn 17, Issue 7, 2011, Pages 520-526

  Ma, Qing Quan ^a   Shan, An Shan ^a   Dong, Na ^a   Gu, Yao ^a   Sun, Wen Yu ^a   Hu, Wan Ning ^a   Feng, Xing Jun ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antimicrobial peptides; Cell selectivity; Haemolysis; in vivo; Liposomes

Indexed keywords

ANTIINFECTIVE AGENT; ARGININE; PEPTIDE; PEPTIDE G1; PEPTIDE G2; PEPTIDE G3; PEPTIDE G4; PEPTIDE G5; PEPTIDE G6; PHOSPHOLIPID; PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG; VALINE;

ALPHA HELIX; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; ARTIFICIAL MEMBRANE; BACTERIAL COUNT; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL INTERACTION; CELL MEMBRANE; CELL SELECTION; CIRCULAR DICHROISM; COMBINATORIAL LIBRARY; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SURVIVAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ARGININE; CELL MEMBRANE; CIRCULAR DICHROISM; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHOSPHOLIPIDS; VALINE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 79958797527     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1360     Document Type: Article

References (40)

1. Sato H, Feix JB. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptides. Biochim. Biophys. Acta. 2006; 1758: 1245-1256.
2. Boman HG. Antibacterial peptides: key components needed in immunity. Cell 1991; 65: 205-207.
3. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66: 236-248.
4. Tossi A, Tarantino C, Romeo D. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. Eur. J. Biochem. 1997; 250: 549-558.
5. Yamada Y, Miura Y, Sakaki A, Yoshida T, Kobayashi K. Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity. Bioorg. Med. Chem. 2006; 14: 77-82.
6. Hong SY, Oh JE, Kwon MY, Choi MJ, Lee JH, Lee BL, Moon HM, Lee KH. Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. Antimicrob. Agents Chemother. 1998; 42: 2534-2541.
7. Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. Int. J. Antimicrob. Agents. 2008; 32: 130-138.
8. Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Montelaro RC, Mietzner TA. De novo generation of cationic antimicrobial peptides: Influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 2005; 49: 316-322.
9. Duval E, Zatylny C, Laurencin M, Baudy-Floc'h M, Henry J. KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity. Peptides 2009; 30: 1608-1612.
10. Wang P, Nan YH, Yang S, Kang SW, Kim Y, Park I, Kyung-Soo H, Shin SY. Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich α-helical model antimicrobial peptide and its diastereomeric peptides. Peptides 2010; 31: 1251-1261.
11. Zelezetsky I, Tossi A. Alpha-helical antimicrobial peptides-Using a sequence template to guide structure-activity relationship studies. Biochim. Biophys. Acta. 2006; 1758: 1436-1449.
12. Chen Y, Mant CT, Hodges RS. Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic α-helix. J. Pept. Res. 2002; 59: 18-33.
13. Brown KL, Hancock REW. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 2006; 18: 24-30.
14. Pellegrini A, Fellenberg R. Design of synthetic bactericidal peptides derived from the bactericidal domain P(18-39) of aprotinin. Biochim. Biophys. Acta. 1999; 1433: 122-131.
15. Shafer WM, Hubalek F, Huang M, Pohl J. Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content. Infect. Immun. 1996; 64: 4842-4845.
16. Cornut I, Büttner K, Dasseux JL, Dufourcq J. The amphipatic α-helix concept: application to the de novo of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than that of melittin. FEBS. Lett. 1994; 349: 29-33.
17. Javadpour MM, Juban MM, Lo WC, Bishop SM, Alberty JB, Cowell SM, Becker CL, McLaughlin ML. De novo antimicrobial peptides with low mammalian cell toxicity. J. Med. Chem. 1996; 39: 3107-3113.
18. Tew GN, Liu D, Chen B, Doerksen RJ, Kaplan J, Carroll PJ, Carroll PJ, Klein ML, DeGrado WF. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. USA 2002; 99: 5110-5114.
19. Schiffer M, Edmundson AB. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys. J. 1967; 7: 121-135.
20. Liu LP, Deber CM. Uncoupling hydrophobicity and helicity in transmembrane segments. J. Biol. Chem. 1998; 273: 23645-23648.
21. Steinberg DA, Hurst MA, Fujii CA, Kung AHC, Ho JF, Cheng FC, Loury DJ, Fiddes JC. Protegrin-1: a broad spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 1997; 41: 1738-1742.
22. Stark M, Liu LP, Deber CM. Cationic hydrophobic peptides with antimicrobial activity. Antimicrob. Agents Chemother. 2002; 46: 3585-3590.
23. Lee KH, Lee DG, Park Y, Kand DI, Shin SY, Hahm KS, Kim Y. Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori. Biochem. J. 2006; 394: 105-114.
24. Yang ST, Shin SY, Lee CW, Kim YC, Hahm KS, Kim JI. Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure. FEBS. Lett. 2003; 540: 229-233.
25. Song YM, Yang ST, Lim SS, Kim Y, Hahm KS, Kim JI, Shin SY. Effects of L- or D-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic a-helical model peptide on structure and cell selectivity. Biochem. Biophys. Res. Commun. 2004; 314: 615-621.
26. Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem. Biophys. Res. Commun. 2006; 349: 769-774.
27. Falla TJ, Hancock REW. Improved activity of a synthetic indolicidin analog. Antimicrob. Agents Chemother. 1997; 41: 771-775.
28. Ibrahim HR, Sugimoto Y, Aoki T. Ovotransferrin antimicrobial peptide (OTAT-92) kills bacteria through a membrane damage mechanism. Biochim. Biophys. Acta. 2000; 1523: 196-205.
29. Fauchere JL, Pliska VE. Hydrophobic parameters p of amino-acid side chains from the partitioning of N-acetyl-amino-acid amides. Eur. J. Med. Chem. 1983; 18: 369-375.
30. Juretić D, Vukićević D, Ilić N, Antcheva N, Tossi A. Computational design of highly selective antimicrobial peptides. J. Chem. Inf. Model. 2009; 49: 2873-2882.
31. Tossi A, Sandri L, Giangaspero A. New consensus hydrophobicity scale extended to non-proteinogenic amino acids, Peptides 2002: Proceedings of the Twenty-seventh European Peptide Symposium. Edizioni Ziino, Napoli, Italy, 2002; 416-417.
32. Chen Y, Mant CT, Farmer SW, Hancock REW, Vasil ML, Hodges RS. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005; 280: 12316-12329.
33. Epand RF, Lehrer RI, Waring A, Wang W, Maget-Dana R, Lelièvre D, Epand RM. Direct comparison of membrane interactions of model peptides composed of only Leu and Lys residues. Biopolymers 2003; 71: 2-16.
34. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1999; 1462: 1-10.
35. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1999; 1462: 55-70.
36. Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of α-helical antimicrobial peptides. Antimicrob. Agents Chemother. 2007; 51: 1398-1406.
37. Oren Z, Shai Y. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Biochemistry 2000; 39: 6103-6114.
38. Pacor S, Giangaspero A, Bacac M, Sava G, Tossi A. Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. J. Antimicrob. Chemother. 2002; 50: 339-348.
39. Schibli DJ, Epand RF, Vogel HJ, Epand RM. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem. Cell. Biol. 2002; 80: 667-677.
40. Raja SM, Rawat SS, Chattopadhyay A, Lala AK. Localization and environment of tryptophans in soluble and membrane-bound states of a pore-forming toxin from Staphylococcus aureus. Biophys. J. 1999; 76: 1469-1479.